ClinicalTrials.govpublic full text
Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer
chronic myeloproliferative disorders, leukemia, lymphoma, multiple myeloma and plasma cell neoplasm, adult acute myeloid leukemia with 11q23 (mll) abnormalities, adult acute myeloid leukemia with inv(16)(p13;q22), adult acute myeloid leukemia with t(15;17)(q22;q12), adult acute myeloid leukemia with t(16;16)(p13;q22), adult acute myeloid leukemia with t(8;21)(q22;q22), recurrent grade 1 follicular lymphoma, recurrent grade 2 follicular lymphoma, recurrent grade 3 follicular lymphoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 917902
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.